Thromboelastography Market

By Type;

Standard, RapidTEG, Functional Fibrinogen, Platelet Mapping, Heparinase, and Consumables & Disposables

By Application;

Cardio-Pulmonary Bypass Surgery, Liver Transplantation, Trauma, Obstetrics, Neonatology & Pediatrics, and Others

By End User;

Hospitals & Clinics, Blood Banks, Academic Institutes, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn218744908 Published Date: June, 2025 Updated Date: July, 2025

Thromboelastography Market Overview

Thromboelastography Market (USD Million)

Thromboelastography Market was valued at USD 828.16 million in the year 2024. The size of this market is expected to increase to USD 1,347.34 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.


Thromboelastography Market

*Market size in USD million

CAGR 7.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.2 %
Market Size (2024)USD 828.16 Million
Market Size (2031)USD 1,347.34 Million
Market ConcentrationMedium
Report Pages341
828.16
2024
1,347.34
2031

Major Players

  • Haemonetics Corporation
  • Instrumentation Laboratory
  • Framar Hemologix srl
  • Medirox AB
  • Diagnostica Stago
  • Life Diagnostica

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Thromboelastography Market

Fragmented - Highly competitive market without dominant players


The Thromboelastography Market is experiencing strong momentum driven by the increasing emphasis on real-time coagulation analysis in critical care. Over 62% of healthcare settings are adopting these tools for their ability to deliver rapid and comprehensive clotting profiles. The shift toward point-of-care testing and the rising demand for blood conservation methods are opening up numerous opportunities in this specialized diagnostics space.

Growth Opportunities and Expansion
The market is expanding rapidly as nearly 54% of healthcare facilities broaden their use of thromboelastography beyond surgical suites into intensive care, obstetric care, and emergency departments. This widespread application provides expansion opportunities for providers to offer customized coagulation testing. Increased interest in perioperative care optimization further highlights the market’s growth potential.

Strategic Collaborations and Innovation
Strategic initiatives such as partnerships, mergers, and acquisitions are fueling innovation and helping firms scale operations. Approximately 60% of companies in this space are investing in the development of next-gen testing systems to enhance accuracy and efficiency. These moves are essential to expanding market reach and reinforcing the role of innovation in driving competitive advantage.

Future Outlook
Looking ahead, the Thromboelastography Market is projected to witness further growth, with more than 66% of laboratories planning to upgrade to high-precision devices. The focus on personalized healthcare solutions and integrated digital platforms supports a strong future outlook. As clinical workflows evolve, this market will benefit from increasing adoption of technologically advanced, data-driven diagnostic tools.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Thromboelastography Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Advancements in Technology
        2. Expanding Applications in Liver Transplantation and Trauma Care
        3. Rising Awareness about Personalized Medicine
      2. Restraints
        1. Complexity of Interpretation
        2. Competition from Alternative Technologies
        3. Regulatory Compliance Challenges
      3. Opportunities
        1. Focus on Research and Development
        2. Strategic Partnerships and Collaborations
        3. Focus on Therapeutic Monitoring
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Thromboelastography Market, By Type, 2021- 2031(USD Million)
      1. Standard
      2. RapidTEG
      3. Functional Fibrinogen
      4. Platelet Mapping
      5. Heparinase
      6. Consumables & Disposables
    2. Thromboelastography Market, By Application, 2021- 2031(USD Million)
      1. Cardio-pulmonary Bypass Surgery
      2. Liver Transplantation
      3. Trauma
      4. Obstetrics
      5. Neonatology & Pediatrics
      6. Others
    3. Thromboelastography Market, By End User, 2021- 2031(USD Million)
      1. Hospitals & Clinics
      2. Blood Banks
      3. Academic Institutes
      4. Others
    4. Thromboelastography Market, By Geography, 2021- 2031(USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Haemonetics Corporation
      2. Instrumentation Laboratory
      3. Framar Hemologix srl
      4. Medirox AB
      5. Diagnostica Stago
      6. Life Diagnostica
  7. Analyst Views
  8. Future Outlook of the Market